Intravenous Infusions Plc

GHSE-IIL
Ghana Stock Exchange
Healthcare Pharmaceutical Preparations
Global Rank
#48246
Country Rank
#20
Market Cap
1.05 M
Price
0.0037
Change (%)
0.00%
Volume
8,000

Intravenous Infusions Plc's latest marketcap:

1.05 M

As of 08/19/2025, Intravenous Infusions Plc's market capitalization has reached $1.05 M. According to our data, Intravenous Infusions Plc is the 48246th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.

Market Cap 1.05 M
Revenue (ttm) 2.31 M
Net Income (ttm) -59,526.67
Shares Out 274.41 M
EPS (ttm) 0
Forward PE 0.00
Ex-Dividend Date n/a
Earnings Date 11/18/2025
Market Cap Chart
Data Updated: 08/19/2025

Intravenous Infusions Plc's yearly market capitalization.

Intravenous Infusions Plc has seen its market value drop from 12.94 M GHS to 10.98 M GHS since 2020, representing a total decrease of 15.18% and an annual compound decline rate (CAGR) of 3.47%.
Date Market Cap Market Cap(USD) Change (%) Global Rank
08/19/2025 10.98 M $1.05 M -20% 48246
12/20/2024 13.72 M $935,732.44 0% n/a
12/22/2023 13.72 M $1.15 M 25% n/a
11/23/2022 10.98 M $1.12 M -20% n/a
12/30/2021 13.72 M $2.27 M 6.02% n/a
12/22/2020 12.94 M $2.22 M n/a

Company Profile

Intravenous Infusions Plc, a pharmaceutical company, engages in the manufacturing and marketing of intravenous infusions and small volume injectables for therapeutic purposes in Ghana and the West African sub-region.

It offers pethidine, including Chloroquine Phosphate and quinine dihydrochloride injections. The company was incorporated in 1969 and is based in Koforidua, Ghana.

Frequently Asked Questions

MarketCapWatch.com ranks all listed companies worldwide, providing unique insights into market capitalization across industries. As one of the most comprehensive ranking platforms, it covers companies of all sizes and sectors.

Ranking

Copyright © 2025. All rights reserved

Important Disclaimer: All content provided on this website, including hyperlinked pages, related applications, forums, blogs, social media accounts, and other platforms ("the Site"), is for general informational purposes only and sourced from third-party providers. We make no guarantees regarding the accuracy, completeness, or timeliness of the content.

None of the information presented constitutes financial, legal, or professional advice. Users should conduct their own research, evaluation, and verification before making any decisions. Investing and trading carry significant risks that may lead to substantial losses. Therefore, we strongly recommend consulting a qualified financial advisor before taking any action.